Completed OBSERVATIONAL NCT01212562

Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery (IMCX)

Open Label, Phase 3 Study of the Efficacy of Combination of Imiquimod and Cryosurgery in the Treatment of Primary Basal Cell Carcinomas of the Skin

Sponsor: University of Ioannina

Conditions Basal Cell Carcinoma

Interventions Immunocryosurgery

Updated 10 times since 2017 Last updated: Aug 31, 2011 Started: Apr 30, 2007 Primary completion: Apr 30, 2010 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Basal Cell Carcinoma, this trial is completed. The trial is conducted by University of Ioannina and has accumulated 10 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: PHASE3 → None
Aug 2017 — Apr 2018 [monthly]

Completed PHASE3
Jan 2017 — Aug 2017 [monthly]

Completed PHASE3

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Ioannina

Data source: University of Ioannina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ioannina, Greece